Robert Dannfeld is founder and Managing Director of Pharmatio GmbH. After his master studies in biology he worked in the software industry for more than 10 years as software developer, IT consultant, trainer und knowledge manager. In 2004 he moved to clinical research and became self-employed as a freelancing CRA and study manager in 2006. In 2011 he founded the specialty service provider Pharmatio to help biopharmaceutical and medical device companies, contract research organisations and research institutes under public law to conduct their clinical studies performing, effectively and efficiently and to accomplish excellent clinical research.
Samuel Raad is working in clinical research since 2008. He started his career as a study co-ordinator at clinical study sites for pharmaceutical studies of phases II and III in the indications gastroenterology and hematological oncology and investigator-initiated trials of various oncological indications. After graduating as a Master of Clinical Research, he joined a global CRO in 2012. Here he developed into an experienced clinical monitor of numerous pharmaceutical studies of the phases I to IV in the therapy areas oncology, pneumology and neurology and learned about the requirements of the pharmaceutical industry. He is currently acquiring his private pilot license and will then support Pharmatio as a Flying CRA.
Dr. Arne Andresen is working in the pharmaceutical and medical technology industry for more than 35 years, among others as product manager, project manager and senior CRA. He has experience in numerous clinical trials of phases I to IV as well as post-marketing studies of very many indications, including cardiovascular, orthopedic indications as well as rheumatism, infectiology, neurology, psychiatry, oncology, pulmology and orphan drugs. After his studies of chemistry and doctorating as Dr. rer. nat. he started working in companies of the basic materials industry, before he moved to the pharmaceutical industry in 1984. He lives with his family in Hamburg and works for customers all over Europe and worldwide.
Laurie Theurer lives and works in Switzerland in the Zurich / Basel region. She has been working in clinical research since 1999 and is an experienced clinical monitor. Over the course of her career, she has monitored numerous pharmaceutical studies from phase I to IV, observation studies, registry studies and medical device studies. In doing so, she pays particular attention to the communication and maintenance of relationships with investigators and their study teams axnd her role as the main line of communication between the sponsor and the investigator. She holds a Master of Science degree in clinical research from Liverpool John Moores University and speaks English, German, Swiss German and Thai.